Next Generation Infusion Pump Market By Type, Application, Source, Foam, Region Forecast till 2022 to 2032

<p>The global <strong>next generation infusion pump market</strong> holds a forecasted share of <strong>US$ 5059.7 million in 2022</strong> and is likely to surpass <strong>US$ 8509 million by 2032</strong>, moving ahead with a <strong>CAGR of 4.8%</strong> during the forecast period (2022 to 2032).</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Details</td></tr><tr><th scope='row'>Next Generation Infusion Pump Market Value (2022)</th><td>US$ 5059.7 million</td></tr><tr><th scope='row'>Next Generation Infusion Pump Market Anticipated Forecast Value (2032)</th><td>US$ 8509 million</td></tr><tr><th scope='row'>Next Generation Infusion Pump Market Projected Growth Rate (2022 to 2032)</th><td>4.8%</td></tr></tbody></table><p>Report Scope</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Details</td></tr><tr><th scope='row'>Growth Rate</th><td>CAGR of 4.8% from 2022 to 2032</td></tr><tr><th scope='row'>Base Year for Estimation</th><td>2022</td></tr><tr><th scope='row'>Historical Data</th><td>2016 to 2021</td></tr><tr><th scope='row'>Forecast Period</th><td>2022 to 2032</td></tr><tr><th scope='row'>Quantitative Units</th><td>Revenue in USD Million and CAGR from 2022-2032</td></tr><tr><th scope='row'>Report Coverage</th><td>Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis</td></tr><tr><th scope='row'>Segments Covered</th><td>By Type; By Application; By Source; By Foam; Region Forecast till 2032</td></tr><tr><th scope='row'>Countries Covered</th><td>North America; Europe; APEJ; The Latin America; MEA</td></tr><tr><th scope='row'>Key Companies Profiled</th><td>Ivenix, Inc; Zyno medical; B. Braun Melsungen AG; Baxter International, Inc.; Fresnius Kabi AG; F. Hoffmann-la Roche Ltd.; Becton Dickinson and Co.; Johnson &amp; Johnson (U.S.); Pfizer (Hospira) Inc.; Smiths Medical; Others</td></tr><tr><th scope='row'>Customization</th><td>Available Upon Request</td></tr></tbody></table>

<p>全球下一代输液泵市场预计在2022年占据约50.597亿美元的份额，并有望在2032年突破85.09亿美元，在预测期内（2022年至2032年）以4.8%的复合年增长率稳步增长。</p><table><tbody><tr><th scope='row'>报告属性</th><td>详细信息</td></tr><tr><th scope='row'>下一代输液泵市场价值（2022年）</th><td>50.597亿美元</td></tr><tr><th scope='row'>下一代输液泵市场预期预测价值（2032年）</th><td>85.09亿美元</td></tr><tr><th scope='row'>下一代输液泵市场预测增长率（2022年至2032年）</th><td>4.8%</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>报告属性</th><td>详细信息</td></tr><tr><th scope='row'>增长率</th><td>2022年至2032年的复合年增长率4.8%</td></tr><tr><th scope='row'>估算基准年</th><td>2022年</td></tr><tr><th scope='row'>历史数据</th><td>2016年至2021年</td></tr><tr><th scope='row'>预测期</th><td>2022年至2032年</td></tr><tr><th scope='row'>计量单位</th><td>以百万美元计的收入和2022-2032年的复合年增长率</td></tr><tr><th scope='row'>报告覆盖</th><td>收入预测、体积预测、公司排名、竞争格局、增长因素、趋势和定价分析</td></tr><tr><th scope='row'>覆盖细分市场</th><td>按类型；按应用；按来源；按泡沫；至2032年的区域预测</td></tr><tr><th scope='row'>覆盖国家</th><td>北美；欧洲；亚太地区；拉丁美洲；中东和非洲</td></tr><tr><th scope='row'>主要公司简介</th><td>Ivenix, Inc；Zyno医疗；B. Braun Melsungen AG；Baxter International, Inc.；Fresnius Kabi AG；F. Hoffmann-la Roche Ltd.；Becton Dickinson and Co.；Johnson &amp; Johnson（美国）；Pfizer（Hospira）Inc.；Smiths Medical；其他</td></tr><tr><th scope='row'>定制服务</th><td>根据需求提供</td></tr></tbody></table>